ARTICLE | Company News
Cytel, Epimmune infectious diseases, cancer news
June 21, 1999 7:00 AM UTC
CYTL will merge with its Epimmune majority-owned subsidiary and change its name to Epimmune Inc. (see BioCentury, April 5). After completion of the merger, expected on June 30, the company will trade ...